Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients

Obstetrics and Gynecology

Volumn 114, Issue 3, 2009, Pages 530-536

  Resnick, Kimberly ^a   Straughn Jr , J Michael ^a   Backes, Floor ^a   Hampel, Heather ^a   Matthews, Kellie S ^a   Cohn, David E ^a  

^a M 210 Starling Loving Hall ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; COST EFFECTIVENESS ANALYSIS; ENDOMETRIUM CANCER; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENE SEQUENCE; HEALTH CARE COST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICARE; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING;

ADULT; AGE FACTORS; AGED; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC SCREENING; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 69549110049     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181b11ecc     Document Type: Article

References (16)

1. Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 2006;66:7810-7817 (Pubitemid 44289242)
2. Hampel H, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, et al. Comment on: screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients [letter]. Cancer Res 2007;67:9603. (Pubitemid 47535953)
3. Rodríguez-Moranta F, Castells A, Andreu M, Piñol V, Castellví-Bel S, Alenda C, et al. Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colon cancer: a proposal of a newer and simpler set of recommendations. Am J Gastroenterol 2006;101:1104-1111 (Pubitemid 43725327)
4. Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, et al. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer dispositions. Gynecol Oncol 2007;107:159-162 (Pubitemid 47575743)
5. Matthews KS, Estes JM, Conner MG, Manne U, Whitworth JM, Huh WK, et al. Lynch syndrome in women less than 50 years of age with endometrial cancer. Obstet Gynecol 2008;111:1161-1166 (Pubitemid 351620352)
6. Lu KH, Schorge JO, Rodabaugh KJ, Daniels MS, Sun CC, Soliman PT, et al. Prospective determination of lynch syndrome in young women with endometrial cancer. J Clin Oncol 2007;25:5158-5164 (Pubitemid 350232246)
7. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999;116:1453-1456 (Pubitemid 29258894)
8. Cohn DE, Frankel WL, Resnick KE, Zanagnolo V, Copeland LJ, Hampel H, et al. Improved outcomes with an intact DNA mismatch repair system in endometrial cancer. Obstet Gynecol 2006;108:1208-1215 (Pubitemid 44665417)
9. Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 1998;17:2413-2417 (Pubitemid 28515395)
10. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER cancer statistics review, 1975-2005. Based on Nov 2007 SEER data submission, posted 2008. Bethesda (MD): National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2005/. Retrieved June 8, 2009.
11. Buttin BM, Powell MA, Mutch DG, Babb SA, Huettner PC, Edmonston TB, et al. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet 2004;74:1262-1269
12. Casey G, Lindor NM, Papadopoulos N, Thibodeau SN, Moskow J, Steelman S, et al. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA 2005;293:799-809. (Pubitemid 40250363)
13. Goodfellow PJ, Buttin BM, Herzog TJ, Rader JS, Gibb RK, Swisher E, et al. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci U S A 2003;100:5908-5913 (Pubitemid 36576906)
14. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Feasibility of screening for Lynch syndrome among patients with colon cancer. J Clin Oncol 2008;26:5783-5786
15. Modica I, Soslow RA, Black D, Tornos C, Kauff N, Shia J. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma. Am J Surg Pathol 2007;31:744-751 (Pubitemid 46684215)
16. Garg K, Leitao MM Jr, Kauff ND, Hansen J, Kosarin K, Shia J, et al. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Am J Surg Pathol 2009;33:925-933